Business Context and Reporting Period
This Form 8-K Current Report was filed by Aveanna Healthcare Holdings, Inc. (AVAH) on April 1, 2025. The filing discloses the entry into a definitive Agreement and Plan of Merger to acquire Thrive Skilled Pediatric Care, LLC ("Thrive") and its blocker entity.
Key Financial Metrics
The filing does not provide standard financial performance metrics such as revenue, profit, cash flow, margins, debt, or liquidity for the reporting period. The primary financial disclosure relates to the transaction consideration.
- Transaction Consideration: Approximately $75.0 million.
- Payment Structure: Primarily in the form of shares of Aveanna Common Stock, subject to customary purchase price adjustments.
- Securities Issuance: Shares will be issued in reliance on the Section 4(a)(2) exemption from registration under the Securities Act of 1933.
Material Changes
The material change reported is the execution of the Merger Agreement on April 1, 2025. This transaction involves two simultaneous mergers:
- Company Merger: Aveanna Merger Sub, LLC will merge with and into Thrive.
- Blocker Merger: Aveanna Blocker Merger Sub, Inc. will merge with and into SP GE IX-B Thrive Blocker Corp.
Upon completion, Thrive and the Blocker will become wholly-owned subsidiaries of the Purchaser (Pediatric Services of America, LLC, together with Aveanna).
Guidance, Outlook, and Risks
The filing does not contain updated financial guidance, management commentary on future outlook, or specific risk factors beyond the standard conditions of the merger agreement. The transaction is subject to the terms and conditions set forth in the Agreement. A press release announcing the agreement was issued on April 3, 2025.
Investor Verification Checklist
- Verify the final purchase price and any adjustments to the $75.0 million consideration.
- Confirm the exact number of Common Stock shares to be issued and the resulting dilution impact.
- Review the full text of the Agreement and Plan of Merger (not included in this summary) for closing conditions and termination fees.
- Monitor for shareholder approval requirements, if applicable, for the issuance of unregistered securities.